Top Markets
#1 Black Phoenix Black Phoenix +354.94%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +68.90%
#4 OpenEden OpenEden +67.50%
#5 Akedo Akedo +50.90%
#6 BasedHype BasedHype +26.45%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +19.93%
#9 Humanity Humanity +18.04%
#10 Ether.fi Ether.fi +17.36%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Kedudukan dalam Saham #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Harga Saham
$0.00162013
Disegerakkan terakhir: 2025-01-03
Modal Pasaran
$156.25K
Perubahan (1 hari)
0.36%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Cyxone AB (publ) (CYXO)

Kategori

Healthcare
Sejarah harga saham bagi Cyxone AB (publ) (CYXO)
Harga penutupan tertinggi: $0.00 pada 2025-01-01

Harga penutupan terendah: $0.50 pada 2016-06-01
Sejarah harga saham Cyxone AB (publ) dari 2016 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2025 -8.09%
2024 -82.58%
2023 -77.33%
2022 -83.86%
2021 -39.25%
2020 12.33%
2019 61.54%
2018 -80.08%
2017 88.25%
2016 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE